Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America

Abstract

Background: Ovarian cancer is a spectrum of several histologically distinct tumor types that differ in etiology, response to therapy, and prognosis. In resource-limited settings, the diagnosis of ovarian cancer can be challenging. This study describes the distribution of ovarian cancer tumor types in East Africa as well as assessing the diagnostic accuracy by using contemporary methods. Methods: Data from 210 women identified from the records with a diagnosis of ovarian cancer in a period of 15 years were included. Two tissue microarrays were constructed and stained with 20 antibodies relevant to ovarian cancer subtyping. An integrated diagnosis was reached by the review of full Haematoxylin and Eosin stained sections, with consideration of immunohistochemical results. The integrated diagnoses were compared with the original diagnoses, and the degree of agreement was evaluated by percentage and Kappa statistics. Results: Though limited by selection bias, the results suggest lower rates of ovarian cancer in East Africa compared to a North American population from Alberta, Canada. There was a higher proportion of sex cord stromal tumors and germ cell tumors in the East African population. Diagnostic accuracy for main ovarian tumor type categories was substantial (Kappa 0.70), but only fair for specific ovarian carcinoma histotypes (Kappa 0.34). Poor Haematoxylin and Eosin stain was the main factor hindering the correct diagnosis, which was not related to tissue processing. Conclusions: In a resource-limited setting, where immunohistochemistry is not routinely carried out, diagnostic accuracy for the main categories of ovarian carcinoma is substantial and could be further improved by standardization of the basic Haematoxylin and Eosin stain.

Gynecological radiation oncology in sub-Saharan Africa: status, problems and considerations for the future

“…Ovarian cancer is the fourth most common cause of female cancer morbidity (3.7%) and fifth for mortality (4.2%) on the continent. Generally ovarian cancer carries a high risk of late presentation and poor outcomes, but this risk is worse in Africa where diagnostic and treatment capacity is limited 9 10. In modern practice, radiotherapy is typically not employed in the management of ovarian cancer, except for localized palliative treatment 11…”

Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa

“…[4] Traditional diagnostic methods commonly used in SSA, such as tissue biopsies, are invasive, costly, and require specialized medical facilities and expertise. [5] These barriers further impede early detection efforts. However, there is hope in the form of liquid biopsy (LB), an emerging noninvasive diagnostic technique.…”

The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis

“…It contained multiple histological types; the majority was classified as high grade serous (accounting for 30-70%); while less common types included endometrioid (10-20%), mucinous (5-20%), clear cell (3-10%), and undifferentiated (1%) types. [4][5][6] Different histological types might have different pathogenesis, biological behavior, natural history, treatment strategies, and prognosis. Different molecular background might determine different biological behavior, therapeutic sensitivity, and prognosis; BRCA1/2 germline mutations were the strongest known genetic risk factors for EOC and were found in 6-15% of women with EOC.…”